Results 151 to 160 of about 111,478 (253)
High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses. [PDF]
Ding C +13 more
europepmc +1 more source
Favipiravir (T‐705) and the non‐fluorinated counterpart (T‐1106) are antiviral agents that inhibit the RNA‐dependent RNA polymerase (RdRp) of various RNA viruses. The antiviral efficacy of nucleoside analogues is strongly dependent on their intracellular activation by cellular kinases to produce their corresponding triphosphate metabolites (T‐705‐RTP ...
Chris Meier +7 more
wiley +1 more source
In vitro and in vivo evaluation of thapsigargin as an antiviral agent against transmissible gastroenteritis virus. [PDF]
Li Y +8 more
europepmc +1 more source
Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19. [PDF]
Papapanou M +3 more
europepmc +1 more source
4′‐ThioRNA was broadly tolerated across multiple positions in SARS‐CoV‐2‐targeting siRNAs, but full 4'‐thio modification of both strands caused a reduction in RNAi activity. Sense‐strand segmentation improved RNAi and antiviral activity, particularly when the nick was located at position 10 from the 5′‐end of the sense strand, thereby unlocking the ...
Yuhei Nogi +5 more
wiley +1 more source
Blebbistatin as a novel antiviral agent targeting equid herpesvirus type 8. [PDF]
Li L +10 more
europepmc +1 more source
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71). [PDF]
Lalani S, Masomian M, Poh CL.
europepmc +1 more source
Lysosomes play a key role in the accumulation, catabolism, and transport of endogenous and exogenous metabolites and proteins and are involved in drug metabolism and prodrug activation. However, the protein abundance and interindividual variability of lysosomal drug‐metabolizing enzymes and transporters (DMETs) remain underexplored.
Darshak Gadara +20 more
wiley +1 more source
Predicting lung exposure of intramuscular niclosamide as an antiviral agent: Power-law based pharmacokinetic modeling. [PDF]
Kim T +5 more
europepmc +1 more source
The intestinal microbiome is a key regulator of immune homeostasis, metabolism, and epithelial barrier integrity. In patients with malignant hematological diseases, particularly those undergoing hematopoietic stem cell transplantation, microbiome perturbations by reduced diversity, pathobiont expansion, and loss of beneficial metabolites are common as ...
Bálint Gergely Szabó +7 more
wiley +1 more source

